Botulinum toxin type A in the treatment of hemifacial spasm An 11-year experience

被引:22
作者
Barbosa, Egberto Reis [1 ]
Takada, Leonel Tadao [1 ]
Goncalves, Lilian Regina [1 ]
Paulo do Nascimento Costa, Rose Mary [1 ]
Silveira-Moriyama, Laura [2 ]
Chien, Hsin Fen [1 ]
机构
[1] Univ Sao Paulo, Movement Disorders Unit, Div Neurol, Sch Med, Sao Paulo, Brazil
[2] UCL Inst Neurol, Reta Lila Weston Inst Neurol Studies, London, England
关键词
botulinum toxin; hemifacial spasm; BLEPHAROSPASM; EFFICACY;
D O I
10.1590/S0004-282X2010000400006
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
In order to evaluate the long-term effect of botulinum toxin type A (BTX) in the treatment of hemifacial spasm (HFS), a retrospective analysis of patients treated at the Movement Disorders Unit of the Division of Neurology, Clinical Hospital, University of Sao Paulo, School of Medicine from 1993 to 2004 was made. A total of 808 injections with BTX were administered to 54 patients with HFS. The mean duration of improvement per application was 3.46 months and the mean rate of improvement using subjective judgement by the patient was of 83%. Adverse effects, mostly minor, were observed in 64.8% of patients at least once along the period of follow-up and the most frequent of them was orbicularis oris paralysis (38.8%). There was no decrement in response when compared the first and the last injection recorded.
引用
收藏
页码:502 / 505
页数:4
相关论文
共 14 条
[1]  
BIGLAN AW, 1988, ARCH OTOLARYNGOL, V114, P1407
[2]  
BRIN M, 1993, AM AC NEUR ANN COURS, V2
[3]  
CONSKY E, 1991, WORSH DEP NEUR ESC P
[4]   Botulinum toxin A treatment for primary hemifacial spasm -: A 10-year multicenter study [J].
Defazio, G ;
Abbruzzese, G ;
Girlanda, P ;
Vacca, L ;
Currà, A ;
De Salvia, R ;
Marchese, R ;
Raineri, R ;
Roselli, F ;
Livrea, P ;
Berardelli, A .
ARCHIVES OF NEUROLOGY, 2002, 59 (03) :418-420
[5]   Clinical assessment of patients with primary and postparalytic hemifacial spasm - A retrospective study [J].
Felicio, Andre Carvalho ;
Godeiro-Junior, Clecio de Oliveira ;
Borges, Vanderci ;
de Azevedo Silva, Sonia Maria ;
Ferraz, Henrique Ballalai .
ARQUIVOS DE NEURO-PSIQUIATRIA, 2007, 65 (3B) :783-786
[6]  
GREEAR JN, 1954, T AM OPHTHAL SOC, V52, P447
[7]   Long-term efficacy of botulinum toxin A in treatment of various movement disorders over a 10-year period [J].
Hsiung, GYR ;
Das, SK ;
Ranawaya, R ;
Lafontaine, AL ;
Suchowersky, O .
MOVEMENT DISORDERS, 2002, 17 (06) :1288-1293
[8]   Long term results of botulinum toxin type A (Dysport) in the treatment of hemifacial spasm: a report of 175 cases [J].
Jitpimolmard, S ;
Tiamkao, S ;
Laopaiboon, M .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1998, 64 (06) :751-757
[9]   Botulinum toxin in the treatment of blepharospasm and hemifacial spasm [J].
Kenney, C. ;
Jankovic, J. .
JOURNAL OF NEURAL TRANSMISSION, 2008, 115 (04) :585-591
[10]   Treatment choices of 119 patients with hemifacial spasm over 11 years [J].
Mauriello, JA ;
Leone, T ;
Dhillon, S ;
Pakeman, B ;
Mostafavi, R ;
Yepez, MC .
CLINICAL NEUROLOGY AND NEUROSURGERY, 1996, 98 (03) :213-216